Healthy volunteers test new injection method for Infection-Fighting drug
NCT ID NCT06918587
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new way to give a drug for febrile neutropenia (a serious fever with low white blood cells) in 180 healthy adults. Researchers compared how the body absorbs the drug when given by a prefilled syringe versus an on-body injector. They also monitored safety and checked for immune reactions to the drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FEBRILE NEUTROPENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Al-Essra Hospital
Amman, Jordan, 11941, Jordan